Intellia Therapeutics, building exterior and company sign, Cambridge, Massachusetts, USA.Spencer Scholarship | Universal Images Group | Getty ImagesIntellia Therapeutic said…
Trending
- Some jurors selected in the Musk v. Altman trial expressed negative feelings toward Elon Musk and AI, but assured the court they would put those concerns aside (Wired)
- Xiaomi open sources MiMo-V2.5 and MiMo-V2.5-Pro under the MIT license, claiming that both models are among the most efficient available for “claw” agent tasks (Carl Franzen/VentureBeat)
- Tired Hakeem Jeffries Calls Karoline Leavitt a Disgrace and a Cold Liar
- Lp(a) drugs from Novartis, Amgen and Eli Lilly aim to prevent heart attacks
- Intellia’s Crispr gene-editing treatment passes phase 3 trial
- Have I been pwned: ShinyHunters’ ADT breach exposed personal data of 5.5 million people; ADT has already disclosed data breaches in August 2024 and October 2024 (Sergiu Gatlan/BleepingComputer)
- The stock falls following weak sales
- Kashable, which allows businesses to offer "socially responsible" credit and financial wellness programs for employees as a voluntary benefit, raised $60 million Series C (Mary Ann Azevedo/Crunchbase News)
